Hancock Whitney Corp acquired a new stake in Cigna Corp (NYSE:CI) in the 4th quarter, Holdings Channel reports. The fund acquired 11,925 shares of the health services provider’s stock, valued at approximately $2,265,000.

Several other hedge funds also recently modified their holdings of CI. 1 North Wealth Services LLC acquired a new stake in shares of Cigna in the fourth quarter valued at $25,000. Private Ocean LLC acquired a new stake in Cigna in the 4th quarter worth $26,000. Delta Asset Management LLC TN acquired a new stake in Cigna in the 4th quarter worth $28,000. Litman Gregory Asset Management LLC acquired a new stake in Cigna in the 4th quarter worth $30,000. Finally, Parisi Gray Wealth Management acquired a new stake in Cigna in the 4th quarter worth $32,000. 88.30% of the stock is owned by institutional investors and hedge funds.

In related news, insider Michael W. Triplett sold 9,148 shares of Cigna stock in a transaction dated Monday, February 11th. The shares were sold at an average price of $181.01, for a total transaction of $1,655,879.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director John Partridge sold 1,000 shares of Cigna stock in a transaction dated Thursday, February 7th. The shares were sold at an average price of $184.43, for a total transaction of $184,430.00. The disclosure for this sale can be found here. Insiders have sold a total of 10,420 shares of company stock valued at $1,886,122 over the last three months. 0.80% of the stock is currently owned by insiders.

CI has been the topic of several research analyst reports. Morgan Stanley started coverage on shares of Cigna in a research report on Thursday, December 13th. They issued an “overweight” rating and a $304.00 price target on the stock. Edward Jones started coverage on shares of Cigna in a report on Monday, December 24th. They set a “buy” rating and a $181.30 price objective for the company. ValuEngine downgraded shares of Cigna from a “hold” rating to a “sell” rating in a report on Friday, December 28th. Raymond James raised shares of Cigna from a “market perform” rating to an “outperform” rating and set a $187.17 price objective for the company in a report on Thursday, January 3rd. Finally, Zacks Investment Research downgraded shares of Cigna from a “buy” rating to a “hold” rating in a report on Thursday, January 3rd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and thirteen have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $231.28.

NYSE:CI opened at $164.44 on Tuesday. The stock has a market cap of $62.24 billion, a PE ratio of 11.56, a price-to-earnings-growth ratio of 0.82 and a beta of 0.73. Cigna Corp has a 52 week low of $162.42 and a 52 week high of $226.60. The company has a quick ratio of 0.42, a current ratio of 0.42 and a debt-to-equity ratio of 0.96.

Cigna (NYSE:CI) last released its quarterly earnings data on Friday, February 1st. The health services provider reported $2.46 EPS for the quarter, missing analysts’ consensus estimates of $2.53 by ($0.07). Cigna had a return on equity of 16.64% and a net margin of 5.42%. The business had revenue of $13.75 billion for the quarter, compared to the consensus estimate of $11.38 billion. During the same period in the previous year, the business posted $1.94 earnings per share. Cigna’s revenue was up 29.3% on a year-over-year basis. On average, equities research analysts expect that Cigna Corp will post 16.41 EPS for the current year.

The company also recently declared a special dividend, which will be paid on Wednesday, April 10th. Investors of record on Monday, March 11th will be issued a dividend of $0.04 per share. The ex-dividend date of this dividend is Friday, March 8th. Cigna’s dividend payout ratio is currently 0.28%.

TRADEMARK VIOLATION WARNING: This report was first posted by Watch List News and is the property of of Watch List News. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://www.watchlistnews.com/hancock-whitney-corp-takes-2-27-million-position-in-cigna-corp-ci/2919222.html.

Cigna Profile

Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.

Read More: Why is a lock-up period needed for an IPO?

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.